Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework.

MLA

Maury, Pauline, et al. “Clinical Transfer of AGuIX®-Based Radiation Treatments for Locally Advanced Cervical Cancer: MR Quantification and in Vitro Insights in the NANOCOL Clinical Trial Framework.” Nanomedicine : Nanotechnology, Biology, and Medicine, vol. 50, June 2023, p. 102676. EBSCOhost, https://doi.org/10.1016/j.nano.2023.102676.

APA

Maury, P., Mondini, M., Chargari, C., Darricau, A., Shahin, M., Ammari, S., Bockel, S., Genestie, C., Wu, T.-D., Lux, F., Tillement, O., Lacombe, S., Deutsch, E., Robert, C., & Porcel, E. (2023). Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework. Nanomedicine : Nanotechnology, Biology, and Medicine, 50, 102676. https://doi.org/10.1016/j.nano.2023.102676

Chicago

Maury, Pauline, Michele Mondini, Cyrus Chargari, Arthur Darricau, Mona Shahin, Samy Ammari, Sophie Bockel, et al. 2023. “Clinical Transfer of AGuIX®-Based Radiation Treatments for Locally Advanced Cervical Cancer: MR Quantification and in Vitro Insights in the NANOCOL Clinical Trial Framework.” Nanomedicine : Nanotechnology, Biology, and Medicine 50 (June): 102676. doi:10.1016/j.nano.2023.102676.